Clinical trial · Observational
Early Diagnosis and Treatment Standardization of Delirium
NCT03199859CI-TRIAL-00040752completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
1. Observe the characteristics of delirium patients, searching for early diagnostic methods or finding risk factors 2. Design a guideline for delirium, diagnosis or treatment
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Delirium | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Delirium Rating Scale-98
- timeFrame
- Till 1 year after surgery
- description
- Delirium rating tool, score of 8 for subsyndromal delirium, 15 for delirium
Secondary outcomes (1)
- measure
- Functional assessment of cancer therapy - gastric cancer
- timeFrame
- Till 1 year after surgery
- description
- Quality of life measuring tool for gastric cancer
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Curable malignant gastric cancer Exclusion Criteria: * Gastrointestinal stromal tumor * Uncurable cancer
References
Publications (0)
Data not yet available
No reference posted for this study.